Found: 1140
Select item for more details and to access through your institution.
Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol.
- Published in:
- Pathology & Oncology Research, 2024, p. 1, doi. 10.3389/pore.2024.1611720
- By:
- Publication type:
- Article
Special Issue "Genetic, Functional and Therapeutic Aspects of Procoagulant and Anticoagulant Factors".
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 5741, doi. 10.3390/ijms25115741
- By:
- Publication type:
- Article
Liposomal factor VIII as an efficient pharmaceutical system for the treatment of hemophilia.
- Published in:
- Iranian Journal of Basic Medical Sciences, 2024, v. 27, n. 6, p. 747, doi. 10.22038/IJBMS.2024.74673.16214
- By:
- Publication type:
- Article
Aberrant methylation and expression of TNXB promote chondrocyte apoptosis and extracullar matrix degradation in hemophilic arthropathy via AKT signaling.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.93087
- By:
- Publication type:
- Article
Analyzing and modeling massive transfusion strategies and the role of fibrinogen—How much is the patient actually receiving?
- Published in:
- Transfusion, 2024, v. 64, p. S136, doi. 10.1111/trf.17774
- By:
- Publication type:
- Article
Non-viral and viral delivery systems for hemophilia A therapy: recent development and prospects.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 5, p. 1493, doi. 10.1007/s00277-023-05459-0
- By:
- Publication type:
- Article
Concomitant large deletion and de novo duplication of factor VIII gene in an Indian patient with severe Hemophilia A.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 5, p. 1789, doi. 10.1007/s00277-024-05661-8
- By:
- Publication type:
- Article
Hemophilic pseudotumor of the knee joint: Emphasizing prevention and early diagnosis in a rare disease.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
A post hoc analysis of PROTECT VIII kids assessing long‐term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 5, p. 756, doi. 10.1111/ejh.14167
- By:
- Publication type:
- Article
Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 577, doi. 10.1111/hae.15001
- By:
- Publication type:
- Article
Genetic variant detection in a South African haemophilia B population.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 765, doi. 10.1111/hae.14978
- By:
- Publication type:
- Article
Acquired hemophilia A in a case of purple urine bag syndrome.
- Published in:
- Italian Journal of Medicine, 2024, v. 18, n. 2, p. 1, doi. 10.4081/itjm.2024.1713
- By:
- Publication type:
- Article
Impact of Replacement Therapy on Pregnancy Outcomes in Hemophilia Carriers: A Historical Cohort Study in Saudi Arabia.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 5, p. 623, doi. 10.3390/life14050623
- By:
- Publication type:
- Article
Factor VIII moiety of recombinant Factor VIII Fc fusion protein impacts Fc effector function and CD16<sup>+</sup> NK cell activation.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1341013
- By:
- Publication type:
- Article
Poly I:C elicits broader and stronger humoral and cellular responses to a Plasmodium vivax circumsporozoite protein malaria vaccine than Alhydrogel in mice.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1331474
- By:
- Publication type:
- Article
Current and emerging gene therapies for haemophilia A and B.
- Published in:
- Haemophilia, 2024, v. 30, p. 12, doi. 10.1111/hae.14984
- By:
- Publication type:
- Article
Benefits and risks of non‐factor therapies: Redefining haemophilia treatment goals in the era of new technologies.
- Published in:
- Haemophilia, 2024, v. 30, p. 39, doi. 10.1111/hae.14976
- By:
- Publication type:
- Article
Haemophilia in the era of novel therapies: Where do inhibitors feature in the new landscape?
- Published in:
- Haemophilia, 2024, v. 30, p. 95, doi. 10.1111/hae.14982
- By:
- Publication type:
- Article
e‐Posters.
- Published in:
- British Journal of Haematology, 2024, v. 204, p. 118, doi. 10.1111/bjh.19399
- Publication type:
- Article
Safety assessments of recombinant DTaP vaccines developed in South Korea.
- Published in:
- Clinical & Experimental Vaccine Research, 2024, v. 13, n. 2, p. 155, doi. 10.7774/cevr.2024.13.2.155
- By:
- Publication type:
- Article
A Generative and Causal Pharmacokinetic Model for Factor VIII in Hemophilia A: A Machine Learning Framework for Continuous Model Refinement.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 4, p. 881, doi. 10.1002/cpt.3203
- By:
- Publication type:
- Article
Impact of Coagulation Factors on the Properties of Fibrin Adsorption Films.
- Published in:
- Colloid Journal, 2024, v. 86, n. 2, p. 258, doi. 10.1134/S1061933X24600052
- By:
- Publication type:
- Article
Risk of Intracranial Hemorrhage in Persons with Hemophilia A in the United States: Real-World Retrospective Cohort Study Using the ATHNdataset.
- Published in:
- Journal of Blood Medicine, 2024, v. 15, p. 191, doi. 10.2147/JBM.S443380
- By:
- Publication type:
- Article
ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 4, p. 486, doi. 10.3390/life14040486
- By:
- Publication type:
- Article
Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxis.
- Published in:
- Orphanet Journal of Rare Diseases, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13023-024-03092-2
- By:
- Publication type:
- Article
Haemophilia and Cancer: A Literature Review.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1770, doi. 10.3390/jcm13061770
- By:
- Publication type:
- Article
The role of microRNAs in defining LSECs cellular identity and in regulating F8 gene expression.
- Published in:
- Frontiers in Genetics, 2024, p. 1, doi. 10.3389/fgene.2024.1302685
- By:
- Publication type:
- Article
Quantitative transcriptome‐based analysis predicts a combination therapy for severe haemophilia B: A case report.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 1105, doi. 10.1111/bjh.19261
- By:
- Publication type:
- Article
Clinical efficacy of simoctocog alfa versus extended half‐life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matching‐adjusted indirect comparison method.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 479, doi. 10.1111/ejh.14130
- Publication type:
- Article
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 257, doi. 10.1111/hae.14944
- By:
- Publication type:
- Article
Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 306, doi. 10.1111/hae.14934
- By:
- Publication type:
- Article
Long‐term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post‐treatment.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 320, doi. 10.1111/hae.14936
- By:
- Publication type:
- Article
Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 336, doi. 10.1111/hae.14963
- By:
- Publication type:
- Article
Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 345, doi. 10.1111/hae.14960
- By:
- Publication type:
- Article
Peri‐operative desmopressin combined with pharmacokinetic‐guided factor VIII concentrate in non‐severe haemophilia A patients.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 355, doi. 10.1111/hae.14946
- By:
- Publication type:
- Article
Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post‐marketing study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 388, doi. 10.1111/hae.14930
- By:
- Publication type:
- Article
Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single‐arm, open‐label study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 395, doi. 10.1111/hae.14932
- By:
- Publication type:
- Article
Unearthing the genotype‐inhibitor phenotype association in severe haemophilia A: A north Indian cohort study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 410, doi. 10.1111/hae.14948
- By:
- Publication type:
- Article
Physical activity and factor VIII levels in patients with haemophilia: A real‐world prospective observational study.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 419, doi. 10.1111/hae.14965
- By:
- Publication type:
- Article
Health‐related quality of life of Indonesian children with hemophilia.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 463, doi. 10.1111/hae.14937
- By:
- Publication type:
- Article
Comparison of one‐stage and chromogenic factor VIII assays to tailor the dose of recombinant factor VIII‐Fc fusion protein (rFVIIIFc, efmoroctocog alfa) in adult patients with haemophilia A: Single‐centre, real‐world experience of surgery
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 538, doi. 10.1111/hae.14929
- By:
- Publication type:
- Article
Measurement of recombinant porcine factor VIII in patients with congenital haemophilia A and inhibitors in the presence of emicizumab.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 545, doi. 10.1111/hae.14955
- By:
- Publication type:
- Article
Development and Validation of an HPLC-UV Method for the Quantification of Acyclovir and Ganciclovir in the Plasma of Pediatric Immunocompromised Patients.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 5, p. 2685, doi. 10.3390/ijms25052685
- By:
- Publication type:
- Article
The Relationship Between the Energization of Moon‐Originating Ions and Terrain Type on the Lunar Surface.
- Published in:
- Journal of Geophysical Research. Space Physics, 2024, v. 129, n. 3, p. 1, doi. 10.1029/2023JA032076
- By:
- Publication type:
- Article
Forty-eight-year follow-up of a female worker exposed to highly enriched uranium via chronic and acute inhalation.
- Published in:
- Radiation & Environmental Biophysics, 2024, v. 63, n. 1, p. 81, doi. 10.1007/s00411-023-01055-y
- By:
- Publication type:
- Article
Telangiectatic osteosarcoma in four dogs: Cytologic, histopathologic, cytochemical, and immunohistochemical findings.
- Published in:
- Veterinary Clinical Pathology, 2024, v. 53, n. 1, p. 85, doi. 10.1111/vcp.13338
- By:
- Publication type:
- Article
A group VIIIa ethylene-responsive factor, CmERF4, negatively regulates waterlogging tolerance in chrysanthemum.
- Published in:
- Journal of Experimental Botany, 2024, v. 75, n. 5, p. 1479, doi. 10.1093/jxb/erad451
- By:
- Publication type:
- Article
Tolerability, safety, and pharmacokinetics of a single intravenous administration of a novel recombinant humanized anti-interleukin-6 receptor monoclonal antibody in healthy Chinese volunteers.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2023.1267178
- By:
- Publication type:
- Article
Publication Only Abstracts.
- Published in:
- Haemophilia, 2024, v. 30, p. 189, doi. 10.1111/hae.14920
- Publication type:
- Article
Acquired haemophilia A in paediatric patients: A retrospective French cohort of eight cases.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 2, p. 606, doi. 10.1111/bjh.19285
- By:
- Publication type:
- Article